Covington & Burling LLP | FDA Issues Draft Guidance for Dietary Supplement Labeling Urging Use of Full Domestic Address or Telephone Number and Introductory Statement Indicating Use for Reporting Adverse Events

This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.